Epithelial Cell TLRs in Disease Susceptibility
Epithelial Cell TLRs in Disease Susceptibility
批准号:
8009619
负责人:
DENIS F KINANE
金额:
$32.93万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-09 至 2012-05-31
关键词:
AddressAgeArterial Fatty StreakAsthmaBacteriaBiological AssayCD14 geneCell Culture TechniquesCellsCharacteristicsChronicClinical ResearchComplexDNADataDentalDental PlaqueDevelopmentDiagnosticDiseaseDisease susceptibilityEndothelial CellsEpithelialEpithelial CellsEpithelial Receptor CellEpitheliumEtiologyExperimental GeneticsFibroblastsGene Expression ProfilingGenesGenetic PolymorphismGenomicsGenotypeGingivaGingivitisHost DefenseHumanImmuneImmune responseImmune systemIndividualIndividual DifferencesInflammationInflammatoryInflammatory Bowel DiseasesIntestinesLeadLeukocytesLipopolysaccharidesMessenger RNAMicrobeOutcomePatientsPeriodontal DiseasesPeriodontitisPhenotypePlayPorphyromonas gingivalisPredispositionPrimary Cell CulturesProteinsRNA InterferenceReportingResearch PersonnelResistanceRiskRoleSeveritiesSignaling MoleculeSingle Nucleotide PolymorphismSmall Interfering RNASystemSystemic diseaseTLR4 geneTestingTherapeuticToll-like receptorsTooth LossTransfectionTranslatingVariantVascular Endothelial CellWorkbonecase controlcell typechemokinecytokinegastrointestinal epitheliumimmunoreactivityknock-downmicrobialmolecular phenotypemonocytenovel therapeuticspathogenprogramsreceptorreceptor expressionreceptor functionresponsesex
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Humans develop gingivitis and periodontitis in response to the challenges produced by microbial dental plaque. Individuals vary in their susceptibility to both gingivitis (superficial inflammation) and periodontitis (extensive inflammation causing bone and tooth loss). The etiology of periodontal disease is not fully understood; however, it is accepted that variance in the human host response to microbial plaque will relate to the host's innate, inflammatory or immune defense systems. Single nucleotide polymorphisms (SNPs) exist in the human genes encoding many molecules pertinent to the host-microbe interaction. Periodontal inflammation (gingivitis and periodontitis) begins with the perturbation of the epithelial cells by bacteria via receptors, including Toll-like Receptors (TLRs). Our preliminary data indicates that the pro-inflammatory cytokines and chemokines produced in response to bacterial and cytokine perturbations differ between individuals and these differences may relate to carriage of a specific TLR4 polymorphism. Our general hypothesis is that individual response characteristics of gingival epithelial cells to foreign challenges, relate to their cellular TLR genotype which influences susceptibility to gingivitis and periodontitis. Thus we will address the following aims utilizing multiple primary human gingival epithelial cells (HGECs), clinical studies and genotype and phenotype analyses. The first aim is to characterize molecularly the inter-patient differences in TLR expression in HGECs using qPCR, gene expression profiling, protein assays and immunoreactivity and to correlate this to the TLR genotype. Secondly, functional analysis of genetically- modified HGECs (using siRNA knock-downs and over-expression) will elucidate the role of TLR4 and the Asp299Gly and other SNPs in epithelial LPS hypo-responsiveness. Thirdly, we aim to translate this work by determining clinically if TLR4 polymorphisms and hypo-responsiveness correlate with the severity of experimental gingivitis and if they can differentiate periodontitis cases and controls. Finally, we aim to challenge HGECs and other cell types, monocytes, gut epithelia and endothelial cells to assess LPS responsiveness relevant to the etiopathology of TLR4 associated diseases such as inflammatory bowel disease, atheroma and asthma. Characterization of response differences and determination of related SNPs may lead to new therapeutics or diagnostics in a range of infectious and inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetics, dysbiosis and inflammation in epithelial cells
-
批准号:9194402
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2015
-
负责人:DENIS F KINANE
-
依托单位:
Epigenetics, dysbiosis and inflammation in epithelial cells
-
批准号:8816932
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2015
-
负责人:DENIS F KINANE
-
依托单位:
2009 Periodontal Disease GRC
-
批准号:7674163
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2009
-
负责人:DENIS F KINANE
-
依托单位:
Epithelial Cell TLRs in Disease Susceptibility
-
批准号:7828124
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2007
-
负责人:DENIS F KINANE
-
依托单位:
Epithelial Cell TLRs in Disease Susceptibility
-
批准号:7465567
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2007
-
负责人:DENIS F KINANE
-
依托单位:
Epithelial Cell TLRs in Disease Susceptibility
-
批准号:8072572
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2007
-
负责人:DENIS F KINANE
-
依托单位:
Epithelial Cell TLRs in Disease Susceptibility
-
批准号:7315570
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2007
-
负责人:DENIS F KINANE
-
依托单位:
International Conference on Tobacco Induced Diseases
-
批准号:6887916
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2004
-
负责人:DENIS F KINANE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: